On August 8, the Guangzhou GPO (procurement of Guangzhou Pharmaceutical Group) platform under Guangzhou Trading Group released an announcement to adjust the price of domestic new coronavirus treatment drug azvudine tablets. According to the rules, the price was 626.06 yuan / bottle, 35 tablets per bottle, 3mg per tablet. After conversion, the price was less than 6 yuan per 1mg, and the price reduction rate was more than 70%. This means that the oral small molecule novel coronavirus pneumonia (covid-19) treatment drugs independently developed by China can be supplied to the clinic at a more reasonable price through the GPO platform. It is reported that at present, 1897 public and private medical institutions in Guangzhou, Foshan, Qingyuan, Yangjiang, Shaoguan and other cities (including 475 in Guangzhou) have settled in Guangzhou GPO platform to carry out drug group procurement, and uniformly implement the platform's drug procurement price and relevant policies and regulations. According to the website of the State Food and drug administration, the State Food and drug administration, in accordance with the relevant provisions of the drug administration law and the special drug approval procedures, conducted emergency review and approval, and conditionally approved the application of azvudine tablets of Henan Zhenzhen Biotechnology Co., Ltd. to increase the indications for the treatment of novel coronavirus pneumonia, which is used to treat adult patients with common novel coronavirus pneumonia (covid-19). The patients should use drugs under the guidance of doctors strictly according to the instructions. Since the outbreak of novel coronavirus pneumonia (covid-19), under the guidance of the provincial and municipal health care departments, the GPO platform has always insisted on the front line of epidemic prevention and control, spared no effort to promote the reform of centralized procurement to help the epidemic prevention and control. It has carried out several rounds of nucleic acid testing and price joint adjustment, and the cost of epidemic prevention and control has been effectively reduced. Centralized procurement has significantly reduced the price of selected products while maintaining stable supply, and continued to reduce the burden of people on medical treatment, It has achieved good social and economic benefits and enhanced the sense of access of the majority of doctors and patients. (news agency)